Homocysteine and oxidative stress

Amino Acids

Volumn 25, Issue 3-4, 2003, Pages 409-417

  Perna, A F ^a   Ingrosso, D ^a   De Santo, N G ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Cardiovascular risk; Chronic renal failure; Homocysteine; Homocystinuria; Mechanisms of toxicity; Uremia

Indexed keywords

HOMOCYSTEINE;

ACYLATION; AMINO ACID BLOOD LEVEL; AMINO ACID URINE LEVEL; ARTERY DISEASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; EVIDENCE BASED MEDICINE; HEART INFARCTION; ISCHEMIC HEART DISEASE; METHYLATION; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STROKE; UREMIA; VEIN THROMBOSIS;

ANIMALS; CARDIOVASCULAR DISEASES; HOMOCYSTEINE; HOMOCYSTINURIA; HUMANS; HYPERHOMOCYSTEINEMIA; LIPOPROTEINS, LDL; MODELS, BIOLOGICAL; OXIDATIVE STRESS; RISK FACTORS; SUPEROXIDE DISMUTASE;

EID: 0347991793     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-003-0026-8     Document Type: Review

References (68)

1. Baigent C, Burbury K, Wheeler D (2000) Premature cardiovascular disease in chronic renal failure. Lancet 356: 147-152
2. Bellamy MF, McDowell IF, Ramsey MW, Brownlee M, Bones C, Newcombe RG, Lewis MJ (1998) Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation 98: 1848-1852
3. Berman RS, Martin W (1993) Arterial endothelial barrier dysfunction: actions of homocysteine and the hypoxantine-xanthine oxidase free radical generating system. Br J Pharmacol 108: 920-926
4. Blom HL (2000) Consequences of homocysteine export and oxidation in the vascular system. Semin Thromb Hemost 26: 227-427
5. Blom HJ, Engelen DP, Boers GH (1992) Lipid peroxidation in homocysteinemia. J Inherit Metab Dis 15: 419-422
6. Bostom AG, Selhub J, Jacques PF, Rosenberg IH (2001) Power shortage: clinical trials testing the "homocysteine hypothesis" against a background of folic acid-fortified cereal grain flour. Ann Intern Med 135: 133-137
7. Chambers JC, McGregor A, Jean-Marie J, Kooner JS (1998) Acute hyperhomocysteinemia and endothelial dysfunction. Lancet 351: 36-37
8. Chao C, Kuo T, Lee Y (2000) Effects of methionine-induced hyperhomocysteinemia on endothelium-dependent vasodilation and oxidative status in healthy adults. Circulation 101: 485-490
9. Chen RZ, Pettersson U, Beard C Jackson-Grusby L, Jaenisch R (1998) DNA hypomethylation leads to elevated mutation rates. Nature 395: 89-93
10. Chen Z, Karaplis AC, Ackerman SL, Pogribny IP, Melnyk S, Lussier-Cacan S, Chen MF, Pai A, John SW, Smith RS, Bottiglieri T, Bagley P, Selhub J, Rudnicki MA, James SJ, Rozen R (2001) Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet 10: 433-443
11. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I (1991) Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324: 1149-1155
12. De Groote MA, Testerman T, Xu Y, Stauffer G, Fang FC (1996) Homocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium. Science 272: 414-417
13. Drunat S, Moatti N, Paul JL, Cogny A, Benoit MO, Demuth K (2001) Homocysteine-induced decrease in endothelin-1 production is initiated at the extracellular level and involves oxidative products. Eur J Biochem 268: 5287-5294
14. Dudman NP, Wilcken DE, Stocker R (1993) Circulating lipid hydroperoxide levels in human hyperhomocysteinemia. Relevance to the development of arteriosclerosis. Arteriosclerosis & Thrombosis 13: 512-516
15. Eikelboom JW, Lonn E, Genest J, Hankey G, Yusuf S (1999) Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Inter Med 131: 363-375
16. El-Khairy L, Ueland PM, Refsum H, Graham IM, Vollset SE. European Concerted Action Project (2001) Plasma total cysteine as a risk factor for vascular disease: The European Concerted Action Project. Circulation 103: 2544-2549
17. Friso S, Choi SW, Girelli D, Mason JB, Dolnikowski GG, Bagley PJ, Olivieri O, Jacques PF, Rosenberg IH, Corrocher R, Selhub J (2002) A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA 99: 5606-5611
18. Halvorsen B, Brude I, Drevon CA, Nysom J, Ose L, Christiansen EN, Nenseter MS (1996) Effect of homocysteine on copper ion-catalyzed, azo compound-initiated, and mononuclear cell-mediated oxidative modification of low density lipoprotein. J Lipid Res 37: 1591-1600
19. Hofmann MA, Lalla E, Lu Y, Gleason MR, Wolf BM, Tanji N, Ferran LJ, Kohl B, Rao V, Kisiel W, Stern DM, Schmidt AM (2001) Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest 107: 675-683
20. Homocysteine studies collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke. JAMA 288(16): 2015-2022
21. Ingrosso D, Cimmino A, Perna AF, Masella L, De Santo NG, De Bonis ML. Vacca M, D'Esposito M, D'Urso M, Galletti P, Zappia V (2003) Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uremia. Lancet 361: 1693-1699
22. Jacobsen DW (2000) Hyperhomocysteinemia and oxidative stress. Time for a reality check? Arterioscler Throm Vasc Biol 20: 1182-1184
23. Jacobsen DW (2001) Cellular mechanisms of homocysteine pathogenesis in atherosclerosis. In: Ralph Carmel Jacobsen DW (eds) Homocysteine in health and disease. Cambridge University Press, UK, pp 425-440
24. Jacobsen DW, Savon SR, Stewart RW, Robinson K, Green R, Kottke-Marchant K, Di Corleto PE (1995) Limited capacity for homocysteine catabolism in vascular cells and tissues: A pathophysiologic mechanism for arterial damage in hyperhomocysteinemia? Circulation 91: 29-33
25. Jakubowski H (1997) Metabolism of homocysteine thiolactone in human cell coltures. Possible mechanism for pathological consequences of elevated homocysteine levels. J Biol Chem 272: 1935-1942
26. Jakubowski H (1999) Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels. FASEB J 13: 2277-2283
27. Jakubowski H (2000a) Calcium-dependent human serum homocysteine thiolactone hydrolase. J Biol Chem 275: 3957-3962
28. Jakubowski H (2000b) Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans. J Nutr 130: 377S-381S
29. Jakubowski H (2000c) Translational incorporation of S- nitrosohomocysteine into protein. J Biol Chem 275: 21813-21816
30. Jakubowski H, Goldman E (1993) Synthesis of homocysteine thiolactone by methionyl-tRNA synthetase in cultured mammalian cells. FEBS 317: 237-240
31. Kanani PM, Sinkey CA, Browning RL, Allaman BA, Knapp HR, Haynes WG (1999) Role of oxidant stress in endothelial dysfunction produced by hyperhomocysteinemia in humans. Circulation 100: 1161-1168
32. Kang SS, Wong PWK, Malinow MR (1992) Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Ann Rev Nutr 12: 279-298
33. Kerins DM, Koury MJ, Capdevila A, Rana S, Wagner C (2001) Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine. Am J Clin Nutr 74: 723-729
34. Kim E, Lowenson JD, MacLaren DC, Clarke S, Young SG (1997) Deficiency of a protein-repair enzyme results in the accumulation of altered proteins, retardation of growth, and fatal seizures in mice. Proc Natl Acad Sci USA 94: 6132-6137
35. Kohnen SL, Mouithys-Mickalad AA, Deby-Dupont GP, Deby CMT, Lamy ML, Noels AF (2001) Oxidation of tetrahydrobiopterin by peroxynitrite or oxoferryl species occurs by a radical pathway. Free Radical Research 35: 709-721
36. Loscalzo J (1996) The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest 98: 5-7
37. Lynch SM, Frei B (1997) Physiological thiol compounds exert pro- and anti-oxidant effects, respectively, on iron- and copper-dependent oxidation of human low-density lipoprotein. Biochim Biophys Acta 1345: 215-221
38. Lynch SM, Campione AL, Moore MK (2000) Plasma thiols inhibit hemin-dependent oxidation of human low-density lipoprotein. Biochim Biophys Acta 1485: 11-22
39. Mansoor MA, Guttormsen AB, Fiskerstrand T, Refsum H, Ueland PM, Svardal AM (1993a) Redox status and protein binding of plasma aminothiols during the transient hyperhomocysteinemia that follows homocysteine administration. Clin Chem 39: 980-985
40. Mansoor MA, Ueland PM, Aarsland A, Svardal AM (1993b) Redox status and protein binding of plasma homocysteine and other aminothiols in patients with homocystinuria. Metabolism 42: 1481-1485
41. Matthews RG, Kaufman S (1980) Characterization of the dihydropterin reductase activity of pig liver methylenetetrahydrofolate reductase. J Biol Chem 255: 6014-6017
42. McCully KS (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of atherosclerosis. Am J Pathol 56: 111-128
43. Mezzano D, Pais EO, Aranda E, Panes O, Downey P, Ortiz M, Tagle R, Gonzalez F, Quiroga T, Caceres MS, Leighton F, Pereira J (2001) Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. Kidney Int 60: 1844-1850
44. Nakano E, Higgins JA, Powers HJ (2001) Folate protects against oxidative modification of human LDL. Br J Nutr 86: 637-639
45. Nappo F, De Rosa N, Marfella R, De Lucia D, Ingrosso D, Perna AF, Farzati B, Giugliano D (1999) Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA 281: 2113-2118
46. Perna AF, Ingrosso D, Zappia V, Galletti P, Capasso G, De Santo NG (1993) Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure: evidence for high levels of the natural inhibitor S-adenosylhomocysteine. J Clin Invest 91: 2497-2503
47. Perna AF, Ingrosso D, De Santo NG, Galletti P, Zappia V (1995) Mechanism of erythrocyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremia. Kidney Int 47: 247-253
48. Perna AF, D'Aniello A, Lowenson JD, Clarke S, De Santo NG, Ingrosso D (1997a) D-aspartate content of erythrocyte membrane proteins is decreased in uremia: implications for the repair of damaged proteins. J Am Soc Nephrol 8: 95-104
49. Perna AF, Ingrosso D, De Santo NG, Galletti P, Brunone M, Zappia V (1997b) Metabolic consequences of folate-induced reduction of hyperhomocysteinemia in uremia. J Am Soc Nephrol 8: 1899-1905
50. Perna AF, Castaldo P, De Santo NG, di Carlo E, Cimmino A, Galletti P, Zappia V, Ingrosso D (2001) Plasma proteins containing damaged L-isoaspartyl residues are increased in uremia: implications for mechanism. Kidney Int 59: 2299-2308
51. Sengupta S, Chen H, Togawa T, DiBello PM, Majors AK, Büdy B, Ketterer ME, Jacobsen DW (2001a) Albumin thiolate anion is an intermediate in the formation of albumin-S-S-homocysteine. J Biol Chem 276: 30111-30117
52. Sengupta S, Wehbe C, Majors AK, Ketterer ME, DiBello PM, Jacobsen DW (2001b) Relative roles of albumin and ceruloplasmin in the formation of homocystine, homocysteine-cysteine-mixed disulfide, and cystine in circulation. J Biol Chem 276: 46896-46904
53. Stamler J, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, Loscalzo J (1993) Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 91: 308-318
54. Starkebaum G, Harlan JM (1986) Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 77: 1370-1376
55. Thambyrajah J, Townend JN (2000) Homocysteine and atherothrombosis - mechanisms for injury. Eur Heart J 21: 967-974
56. Togawa T, Sengupta S, Chen H, Robinson K, Nonevski I, Majors AK, Jacobsen DW (2000) Mechanisms for the formation of protein-bound homocysteine in human plasma. BBRC 277: 668-674
57. Ueland PM, Mansoor MA, Guttormsen AB, Muller F, Aukrust P, Refsum H, Svardal AM (1996) Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status - A possible element of the extracellular antioxidant defense system. J Nutr 126: 1281S-1284S
58. Upchurch GR, Welch G, Fabian A, Freedman J, Johnson J, Keaney J, Loscalzo J (1997) Homocysteine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. 272: 17012-17017
59. Usui M, Matsuoka H, Miyazaki H, Ueda S, Okuda S, Imaizumi T (1999) Endothelial dysfunction by acute hyperhomocysteinemia: restoration by folic acid. Clin Sci 96: 235-239
60. 13C]methionine. Kidney Int 56: 1064-1071
61. Voutilainen S, Morrow JD, Roberts LJ, Alfthan G, Alho H, Nyyssonen K, Salonen JT (1999) Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioscler Thromb Vasc Biol 19: 1263-1266
62. ras methylation in vascular endothelial cells by homocysteine but not cysteine. J Biol Chem 272(40): 25380-25385
63. Weiss N, Heydrick S, Zhang YY, Bierl C, Cap A, Loscalzo J (2002) Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine beta-synthase-deficient mice. Arterioscler Thromb Vasc Biol 22: 34-41
64. Wilcken DEL, Wilcken B (1997) The natural history of vascular disease in homocystinuria and the effects of treatment. J Inherit Metab Dis 20: 295-300
65. Wilcken DEL, Wang XL, Adachi T, Hara H, Duarte N, Green K, Wilcken B (2000) Relationship between homocysteine and superoxide dismutase in homocystinuria. Possible relevance to cardiovascular risk. Arterioscler Throm Vasc Biol 20: 1199-1202
66. Zappacosta B, Mordente A, Persichilli S, Giardina B, De Sole P (2000) Effect of homocysteine on polymorphonuclear leukocyte activity and luminol-dependent chemiluminescence. Luminescence 16: 165-168
67. Zappacosta B, Mordente A, Persichilli S, Minucci A, Carlino P, Martorana GE, Giardina B, De Sole P (2001) Is homocysteine a pro-oxidant? Free Radical Research 35: 499-505
68. Zhang X, Li H, Ebin Z, Brodsky S, Goligorsky MS (2000) Effects of homocysteine on endothelial nitric oxide production. Am J Physiol Renal Physiol 279: F671-F678